Kaitlin Bettens
Physician Assistant · Ann Arbor, MINPI 1144768557
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 833 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 833 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Johnson & Johnson$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Neurocrine Biosciences, Inc.$1K
- plus $6K from 28 others
What the payments were for
- Food & beverage$14,79698%
- Education$2822%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 95 | $1,931 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 81 | $1,791 |
| Johnson & Johnson(2 entities) | 116 | $1,551 |
| Teva Pharmaceuticals USA, Inc. | 57 | $1,226 |
| Otsuka America Pharmaceutical, Inc. | 77 | $1,097 |
| Neurocrine Biosciences, Inc. | 59 | $1,079 |
| Corium, LLC | 45 | $804 |
| Alkermes, Inc. | 31 | $783 |
| Tris Pharma Inc | 38 | $498 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $476 |
| Supernus Pharmaceuticals, Inc. | 23 | $463 |
| Lundbeck LLC | 22 | $360 |
| Idorsia Pharmaceuticals US Inc | 18 | $296 |
| Sage Therapeutics, LLC | 13 | $294 |
| Vanda Pharmaceuticals Inc. | 10 | $290 |
| Axsome Therapeutics, Inc. | 12 | $281 |
| Sunovion Pharmaceuticals Inc. | 21 | $269 |
| Validus Pharmaceuticals LLC | 12 | $235 |
| Indivior Inc. | 13 | $201 |
| Almatica Pharma LLC | 11 | $198 |
| E.r. Squibb & Sons, L.L.C. | 9 | $197 |
| Avanir Pharmaceuticals, Inc. | 8 | $134 |
| Bausch Health US, LLC | 5 | $109 |
| Neos Therapeutics, LP | 4 | $79 |
| Brainsway USA Inc | 1 | $73 |
| Luye Pharma (USA) Ltd. | 4 | $58 |
| OWP Pharmaceuticals, Inc. | 3 | $53 |
| Merck | 3 | $51 |
| Jazz Pharmaceuticals Inc. | 3 | $45 |
| Ironshore Pharmaceuticals Inc. | 2 | $37 |
| Novo Nordisk | 2 | $36 |
| Neuronetics, Inc. | 3 | $32 |
| Adlon Therapeutics L.p. | 2 | $29 |
| Noven Therapeutics, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,078 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 18 | $208,539 |
| VraylarCariprazine Hcl | 26 | $35,998 |
| RexultiBrexpiprazole | 22 | $33,426 |
| TrintellixVortioxetine Hydrobromide | 18 | $20,277 |
| ConcertaMethylphenidate Hcl | 12 | $5,038 |
| Duloxetine Hcl | 120 | $3,494 |
| Aripiprazole | 70 | $3,419 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 74 | $2,163 |
| Lurasidone Hcl | 17 | $2,110 |
| Bupropion XlBupropion Hcl | 79 | $2,001 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 17 | $1,880 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 72 | $1,740 |
| Lamotrigine | 51 | $1,609 |
| Quetiapine Fumarate | 65 | $1,455 |
| Fluoxetine Hcl | 54 | $1,422 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,079 | $208,53918 claims |
| AbbVieVraylar | $1,931 | $35,99826 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,097 | $33,42622 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $476 | $20,27718 claims |
| Johnson & JohnsonConcerta | $1,551 | $5,03812 claims |
| Almatica Pharma LLCSertraline Hcl | $198 | $85455 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Ann Arbor
- Ashley AldridgeAnn Arbor$298K
- Thuy leAnn Arbor$38K
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.